MacroGenics (MGNX) News Today $1.61 +0.03 (+1.90%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.61 0.00 (0.00%) As of 07/11/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MGNX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period MacroGenics (NASDAQ:MGNX) Upgraded by Wall Street Zen to "Hold" RatingJuly 12 at 2:55 AM | marketbeat.comMacroGenics, Inc. (NASDAQ:MGNX) is largely controlled by institutional shareholders who own 71% of the companyJuly 11 at 11:45 AM | finance.yahoo.comMacroGenics (NASDAQ:MGNX) Share Price Crosses Below 200-Day Moving Average - Here's WhyJuly 8, 2025 | marketbeat.comMacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Rating of "Hold" from AnalystsJuly 4, 2025 | americanbankingnews.comMacroGenics, Inc. (MGNX) Latest Stock News & Headlines - Yahoo Finance CanadaJune 29, 2025 | ca.finance.yahoo.comMacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of "Hold" by AnalystsJune 29, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Stock Rating Lowered by Wall Street ZenJune 27, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Shares Pass Below Two Hundred Day Moving Average - Time to Sell?June 18, 2025 | marketbeat.comMacroGenics’ SWOT analysis: biotech firm’s stock faces pivotal year aheadJune 16, 2025 | investing.comMacroGenics lands $70M 'infusion of cash' to advance clinical programsJune 13, 2025 | bizjournals.comMacroGenics: Working On That Road To RecoveryJune 11, 2025 | seekingalpha.comMacroGenics Shares Rise on Royalty-Purchase AgreementJune 10, 2025 | marketwatch.comMacroGenics Target of Unusually Large Options Trading (NASDAQ:MGNX)June 10, 2025 | marketbeat.comMacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase AgreementJune 10, 2025 | globenewswire.comMacroGenics, Inc. (NASDAQ:MGNX) Given Average Recommendation of "Hold" by AnalystsJune 4, 2025 | marketbeat.comMacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025June 3, 2025 | globenewswire.comMacroGenics (NASDAQ:MGNX) Upgraded to Hold at Wall Street ZenMay 31, 2025 | marketbeat.comMillennium Management LLC Sells 671,179 Shares of MacroGenics, Inc. (NASDAQ:MGNX)May 27, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Lowered to "Sell" Rating by Wall Street ZenMay 24, 2025 | marketbeat.comB. Riley Predicts MacroGenics' Q2 Earnings (NASDAQ:MGNX)May 24, 2025 | marketbeat.comZacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion TechnologiesMay 23, 2025 | nasdaq.comMacroGenics, Inc. (NASDAQ:MGNX) Holdings Lifted by Frazier Life Sciences Management L.P.May 23, 2025 | marketbeat.comMacroGenics, Inc. (NASDAQ:MGNX) Shares Sold by Vestal Point Capital LPMay 21, 2025 | marketbeat.com6MGNX : 4 Analysts Assess Macrogenics: What You Need To KnowMay 20, 2025 | benzinga.comDimensional Fund Advisors LP Has $2.33 Million Position in MacroGenics, Inc. (NASDAQ:MGNX)May 17, 2025 | marketbeat.comMacroGenics, Inc.: MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial ResultsMay 16, 2025 | finanznachrichten.deEarnings Release: Here's Why Analysts Cut Their MacroGenics, Inc. (NASDAQ:MGNX) Price Target To US$4.50May 16, 2025 | finance.yahoo.comMacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial ResultsMay 13, 2025 | globenewswire.comA Look at Macrogenics's Upcoming Earnings ReportMay 12, 2025 | benzinga.comMacroGenics, Inc. (NASDAQ:MGNX) Receives Average Rating of "Hold" from AnalystsMay 12, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Decreases Holdings in MacroGenics, Inc. (NASDAQ:MGNX)May 11, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Makes New Investment in MacroGenics, Inc. (NASDAQ:MGNX)May 7, 2025 | marketbeat.comMacroGenics Announces Date of First Quarter 2025 Financial ResultsMay 6, 2025 | globenewswire.comMacroGenics (MGNX) to Release Earnings on ThursdayMay 3, 2025 | marketbeat.comMacroGenics to Participate in Upcoming Investor ConferenceMay 1, 2025 | globenewswire.comRenaissance Technologies LLC Raises Stock Position in MacroGenics, Inc. (NASDAQ:MGNX)April 29, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Shares Pass Below 200 Day Moving Average - Should You Sell?April 27, 2025 | marketbeat.comJPMorgan Chase & Co. Acquires 221,905 Shares of MacroGenics, Inc. (NASDAQ:MGNX)April 27, 2025 | marketbeat.comWasatch Advisors LP Raises Stake in MacroGenics, Inc. (NASDAQ:MGNX)April 19, 2025 | marketbeat.comMacroGenics, Inc. (NASDAQ:MGNX) Receives Average Recommendation of "Hold" from BrokeragesApril 17, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Stock Price Crosses Below Two Hundred Day Moving Average - What's Next?April 10, 2025 | marketbeat.comQ1 Earnings Forecast for MacroGenics Issued By HC WainwrightMarch 28, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Price Target Lowered to $2.00 at HC WainwrightMarch 26, 2025 | marketbeat.comMacroGenics price target lowered to $2 from $4 at H.C. WainwrightMarch 25, 2025 | markets.businessinsider.comMacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of "Hold" by BrokeragesMarch 22, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Rating Lowered to "Hold" at StockNews.comMarch 22, 2025 | marketbeat.comMacroGenics Provides Update on Corporate Progress and 2024 Financial ResultsMarch 22, 2025 | finance.yahoo.comMacroGenics (NASDAQ:MGNX) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPSMarch 22, 2025 | marketbeat.comQ4 2024 MacroGenics Inc Earnings CallMarch 21, 2025 | uk.finance.yahoo.comBarclays Sticks to Their Buy Rating for MacroGenics (MGNX)March 21, 2025 | markets.businessinsider.com Get MacroGenics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address MGNX Media Mentions By Week MGNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGNX News Sentiment▼0.640.99▲Average Medical News Sentiment MGNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGNX Articles This Week▼47▲MGNX Articles Average Week Get MacroGenics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Humacyte News Amarin News Prothena News Benitec Biopharma News Heron Therapeutics News SNDL News Vor Biopharma News Aura Biosciences News Astria Therapeutics News Aerovate Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGNX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MacroGenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MacroGenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
